MAGNI, GIULIA
MAGNI, GIULIA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Activation of glial cells in the cervical spinal cord and in the trigeminal ganglion following induction of inflammatory pain
2012 G. Magni, P.T. Ohara, L. Jasmin, M.P. Abbracchio, S. Ceruti
Adenosine Signaling in Autoimmune Disorders
2020 G. Magni, S. Ceruti
Adult neurogenesis in the subventricular zone: studies on the role of purinergic signalling by the neurosphere assay
2010 M. Boccazzi, G. Magni, C. Rolando, A. Buffo, M.P. Abbracchio, S.M. Ceruti
Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice
2019 G. Magni, M. Boccazzi, A. Bodini, M.P. Abbracchio, A.M. van den Maagdenberg, S. Ceruti
BBB and the purinergic system
2010 G. Magni
Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain
2011 S. Ceruti, G. Villa, M. Fumagalli, L. Colombo, G. Magni, M. Zanardelli, E. Fabbretti, C. Verderio, A.M.J.M. van den Maagdenberg, A. Nistri, M.P. Abbracchio
Corn (ZEA MAYS L). extracts as source of active compounds with promising effects in reducing trigeminal pain through microbiota modulation
2019 G. Magni, C.M. DI LORENZO, F. Colombo, S. Biella, A. Marinelli, D. Lecca, C. Milani, M. Ventura, M.P. Abbracchio, C. Tonelli, P.A. Restani, K. Petroni, S.M. Ceruti
Crosstalk between sensory neurons and neuroinflammatory cells in trigeminal ganglia in relation to migraine pain
2011 E. Fabbretti, S. Ceruti, A. Franceschini, G. Villa, G. Magni, M. Fumagalli, L. Colombo, C. Verderio, A.M. van den Maagdenberg, M.P. Abbracchio, A. Nistri
Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging
2020 G. Lietzau, G. Magni, J. Kehr, T. Yoshitake, E. Candeias, A.I. Duarte, H. Pettersson, J. Skogsberg, M.P. Abbracchio, T. Klein, T. Nystrom, S. Ceruti, V. Darsalia, C. Patrone
Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death
2011 S. Ceruti, F. Viganò, E. Boda, S. Ferrario, G. Magni, M. Boccazzi, P. Rosa, A. Buffo, M. P. Abbracchio
Flavonoids bridging the gut and the brain: intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
2022 G. Magni, B. Riboldi, K. Petroni, S. Ceruti
Glial cell activation and altered metabolic profile in the spinal-trigeminal axis in a rat model of multiple sclerosis associated with the development of trigeminal sensitization
2020 G. Magni, S. Pedretti, M. Audano, D. Caruso, N. Mitro, S. Ceruti
Glial cell activation in the spinal-trigeminal system in vivo : implications for basic mechanisms of pain transmission
2011 G. Magni, G. Villa, M. Zanardelli, P. Ohara, L. Jasmin, M. Abbracchio, S. Ceruti
Il mais pigmentato quale potenziale approccio nella modulazione della sintomatologia associata alla sclerosi multipla : caratterizzazione e dati preliminari in vivo
2022 C. Di Lorenzo, G. Magni, B. Riboldi, S. Biella, F. Colombo, C. Bani, K. Petroni, S. Ceruti
Lipoic-Based TRPA1/TRPV1 antagonist to treat orofacial pain
2015 R. Gualdani, S. Ceruti, G. Magni, D. Merli, L. Di Cesare Mannelli, O. Francesconi, B. Richichi, G. la Marca, C. Ghelardini, M.R. Moncelli, C. Nativi
Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
2022 C. Demartini, R. Greco, G. Magni, A. Maria Zanaboni, B. Riboldi, M. Francavilla, C. Nativi, S.M. Ceruti, C. Tassorelli
Modulation of Glial Cell Functions by the Gut–Brain Axis: A Role in Neurodegenerative Disorders and Pain Transmission
2023 G. Magni, B. Riboldi, S. Ceruti
MODULATION OF GLIAL P2Y RECEPTORS BY ALGOGENIC MEDIATORS IN THE TRIGEMINAL GANGLIA: A ROLE FOR THE PURINERGIC SYSTEM IN THE MECHANISM OF ACTION OF KNOWN ANTI-MIGRAINE DRUGS?
2012 G. Magni, M.P. Abbracchio, S. Ceruti
Modulation of glial P2Y receptors by algogenic mediators in the trigeminal ganglion: a role for the purinergic system in the mechanism of action of known anti-migraine drugs?
2012 G. Magni, S. Melfi, M.P. Abbracchio, S. Ceruti
Nucleotide receptors in trigeminal satellite glial cells as new targets for the pharmacological control of migraine pain: in vitro and in vivo studies
2013 G. Magni, D. Merli, M.P. Abbracchio, S. Ceruti